Population-Level Relative Effectiveness of the COVID-19 Vaccines and the Contribution of Naturally Acquired Immunity
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiac483 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Kayoko Shioda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Emory University, National Institutes of Health.
Abstract (Originalsprache)
Background
Immune protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be induced by natural infection or vaccination or both. Interaction between vaccine-induced immunity and naturally acquired immunity at the population level has been understudied.
Methods
We used regression models to evaluate whether the impact of coronavirus disease 2019 (COVID-19) vaccines differed across states with different levels of naturally acquired immunity from March 2021 to April 2022 in the United States. Analysis was conducted for 3 evaluation periods separately (Alpha, Delta, and Omicron waves). As a proxy for the proportion of the population with naturally acquired immunity, we used either the reported seroprevalence or the estimated proportion of the population ever infected in each state.
Results
COVID-19 mortality decreased as coverage of ≥1 dose increased among people ≥65 years of age, and this effect did not vary by seroprevalence or proportion of the total population ever infected. Seroprevalence and proportion ever infected were not associated with COVID-19 mortality, after controlling for vaccine coverage. These findings were consistent in all evaluation periods.
Conclusions
COVID-19 vaccination was associated with a sustained reduction in mortality at state level during the Alpha, Delta, and Omicron periods. The effect did not vary by naturally acquired immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine Atlanta Georgia USA.
ORCID-Profile: Kayoko Shioda
Förderung
- NIGMS NIH HHS
- Emory University
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Shioda, K., Chen, Y., Collins, M. H., & Lopman, B. A. (2023). Population-Level Relative Effectiveness of the COVID-19 Vaccines and the Contribution of Naturally Acquired Immunity. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac483
Vancouver
Shioda K, Chen Y, Collins MH, Lopman BA. Population-Level Relative Effectiveness of the COVID-19 Vaccines and the Contribution of Naturally Acquired Immunity. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac483
BibTeX
@article{Shioda2023,
author = {Shioda, Kayoko and Chen, Yangping and Collins, Matthew H and Lopman, Benjamin A},
title = {Population-Level Relative Effectiveness of the COVID-19 Vaccines and the Contribution of Naturally Acquired Immunity},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiac483}
}
EUVIMED